Neuraxis, INC

NRXS NYSE SEC CIK 1933567
Follow Neuraxis Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2M +149.9% vs same quarter last year
Net income −$6.5M −208.3% vs same quarter last year
EPS, diluted −$0.52 −116.7% vs same quarter last year
Operating cash flow −$2.3M −58.9% vs same quarter last year
Revenue by quarter
$761.2K
$895.7K
$894.1K
$811.4K
$968.1K
$1.6M
$1.9M
$2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$15M−$10M−$5M$0$5MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$3.6M−$7.8M
FY24$2.7M−$8.2M
FY23$2.5M−$14.6M
FY22$2.7M−$4.8M
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−600%−400%−200%0%200%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2584.2%−219.4%−218.5%
FY2486.5%−266.5%−306.8%
FY2387.7%−270.9%−594.6%
FY2288.9%−125.6%−178%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$6.5M
FY24−$6.1M
FY23−$6.7M
FY22−$2.3M
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Neuraxis
  • Healthcare median
−600%−400%−200%0%FY21FY22FY23FY24FY25
Show the numbers
YearNeuraxisHealthcare median
FY25−218.5%−30.6%
FY24−306.8%−47%
FY23−594.6%−58%
FY22−178%−80.4%
FY21-−71.9%